The medical regulator claims that before allowing the use of the COVID-19 vaccine for adolescents, it carefully analyzed all available data
The United States Food and Drug Administration (FDA) has authorized coronavirus vaccination with a Pfizer/BioNTech drug for children over the age of 12, thus expanding the country’s vaccination program, the pace of which has recently declined.
This is reported by Reuters with reference to the statement of the FDA.
The agency said that thanks to the amendment to the vaccination rules, millions of children aged 12 to 15 years will be able to get vaccinated.
“Today’s decision protects the young population from COVID-19, which will bring us closer to returning to normal and ending the pandemic,” said the acting head of the FDA Janet Woodcock.
She stressed that parents and caregivers can rest assured that the Office conducted a very thorough analysis of all available data before allowing the use of the COVID-19 vaccine for adolescents.
This is the first COVID-19 vaccine approved in the United States for the 12-15-year-old age group.
Most children with COVID-19 show only mild or no symptoms at all, but they remain at risk of becoming seriously ill, and children also spread the virus.
The United States became the second country to approve the use of the Pfizer/BioNTech coronavirus vaccine for children aged 12 and older. A few days earlier, Canada had made the same decision.
